PDF icon PDF herunterladen
Open Access
CC BY-NC-ND 4.0 · Thorac Cardiovasc Surg 2025; 73(02): 174-181
DOI: 10.1055/a-2446-9832
Original Thoracic

A Predictive Model Integrating AI Recognition Technology and Biomarkers for Lung Nodule Assessment

Tao Zhou
1   Department of Cardiothoracic Surgery, Changshu Hospital Affiliated to Soochow University, Changshu, China
,
Ping Zhu
1   Department of Cardiothoracic Surgery, Changshu Hospital Affiliated to Soochow University, Changshu, China
,
Kaijian Xia
1   Department of Cardiothoracic Surgery, Changshu Hospital Affiliated to Soochow University, Changshu, China
,
Benying Zhao
1   Department of Cardiothoracic Surgery, Changshu Hospital Affiliated to Soochow University, Changshu, China
› Institutsangaben
Funding This study was supported by Suzhou City Clinical Key Disease Diagnosis and Treatment Technology Special Project, LCZX202124.
› Weitere Informationen
  Lizenzen und Reprints Alle Artikel dieser Rubrik
Preview

Abstract

Background Lung cancer is the most prevalent and lethal cancer globally, necessitating accurate differentiation between benign and malignant pulmonary nodules to guide treatment decisions. This study aims to develop a predictive model that integrates artificial intelligence (AI) analysis with biomarkers to enhance early detection and stratification of lung nodule malignancy.

Methods The study retrospectively analyzed the patients with pathologically confirmed pulmonary nodules. AI technology was employed to assess CT features, such as nodule size, solidity, and malignancy probability. Additionally, lung cancer blood biomarkers were measured. Statistical analysis involved univariate analysis to identify significant differences among factors, followed by multivariate logistic regression to establish independent risk factors. The model performance was validated using receiver operating characteristic curves and decision curve analysis (DCA) for internal validation. Furthermore, an external dataset comprising 51 cases of lung nodules was utilized for independent validation to assess robustness and generalizability.

Results A total of 176 patients were included, divided into benign/preinvasive (n = 76) and invasive cancer groups (n = 100). Multivariate analysis identified eight independent predictors of malignancy: lobulation sign, bronchial inflation sign, AI-predicted malignancy probability, nodule nature, diameter, solidity proportion, vascular endothelial growth factor, and lung cancer autoantibodies. The combined predictive model demonstrated high accuracy (area under the curve [AUC] = 0.946). DCA showed that the combined model significantly outperformed the traditional model, and also proved superior to models using AI-predicted malignancy probability or the seven lung cancer autoantibodies plus traditional model. External validation confirmed its robustness (AUC = 0.856), achieving a sensitivity of 0.80 and specificity of 0.86, effectively distinguishing between invasive and noninvasive nodules.

Conclusion This combined approach of AI-based CT features analysis with lung cancer biomarkers provides a more accurate and clinically useful tool for guiding treatment decisions in pulmonary nodule patients. Further studies with larger cohorts are warranted to validate these findings across diverse patient populations.

Keywords

pulmonary nodules - artificial intelligence recognition - lung cancer biomarker - predictive model


Publikationsverlauf

Eingereicht: 07. Mai 2024

Angenommen: 01. Oktober 2024

Artikel online veröffentlicht:
26. November 2024

© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany